View Financial HealthSundaram Multi Pap 配当と自社株買い配当金 基準チェック /06Sundaram Multi Pap配当金を支払った記録がありません。主要情報0%配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向0%最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Aug 01Sundaram Multi Pap Limited to Report Q1, 2027 Results on Aug 13, 2026Sundaram Multi Pap Limited announced that they will report Q1, 2027 results on Aug 13, 2026Reported Earnings • May 26Full year 2026 earnings released: EPS: ₹0.07 (vs ₹0.11 loss in FY 2025)Full year 2026 results: EPS: ₹0.07 (up from ₹0.11 loss in FY 2025). Revenue: ₹1.39b (up 9.2% from FY 2025). Net income: ₹31.8m (up ₹83.0m from FY 2025). Profit margin: 2.3% (up from net loss in FY 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings.お知らせ • May 15Sundaram Multi Pap Limited to Report Q4, 2026 Results on May 25, 2026Sundaram Multi Pap Limited announced that they will report Q4, 2026 results on May 25, 2026Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1.29, the stock trades at a trailing P/E ratio of 53x. Average trailing P/E is 26x in the Forestry industry in India. Total loss to shareholders of 48% over the past three years.Reported Earnings • Feb 16Third quarter 2026 earnings released: EPS: ₹0.03 (vs ₹0.057 loss in 3Q 2025)Third quarter 2026 results: EPS: ₹0.03 (up from ₹0.057 loss in 3Q 2025). Revenue: ₹269.3m (up 26% from 3Q 2025). Net income: ₹16.2m (up ₹43.1m from 3Q 2025). Profit margin: 6.0% (up from net loss in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.お知らせ • Feb 06Sundaram Multi Pap Limited to Report Q3, 2026 Results on Feb 14, 2026Sundaram Multi Pap Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 14, 2026New Risk • Dec 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 0.2% per year over the past 5 years. Market cap is less than US$10m (₹824.5m market cap, or US$9.18m). Minor Risk Share price has been volatile over the past 3 months (6.8% average weekly change).Reported Earnings • Nov 15Second quarter 2026 earnings released: EPS: ₹0.02 (vs ₹0.039 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹0.02 (up from ₹0.039 loss in 2Q 2025). Revenue: ₹260.4m (up 8.5% from 2Q 2025). Net income: ₹8.30m (up ₹26.6m from 2Q 2025). Profit margin: 3.2% (up from net loss in 2Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.お知らせ • Nov 04Sundaram Multi Pap Limited to Report Q2, 2026 Results on Nov 13, 2025Sundaram Multi Pap Limited announced that they will report Q2, 2026 results on Nov 13, 2025お知らせ • Oct 17Sundaram Multi Pap Limited announced that it expects to receive INR 235.84 million in fundingSundaram Multi Pap Ltd. (BSE:533166) announced a private placement transaction on October 16, 2025. The company will issue 7,04,00,000 fully Paid-up Equity Shares of the Company having a Face Value of INR 1 each at an issue price of NR 3.35 for gross proceeds of INR 235,840,000 on a preferential basis. The company announced that transaction is subject to approval of shareholders at Extra ordinary general meeting to be held on November 12, 2025.New Risk • Oct 07New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹881.4m (US$9.93m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company.お知らせ • Aug 25Sundaram Multi Pap Limited, Annual General Meeting, Sep 29, 2025Sundaram Multi Pap Limited, Annual General Meeting, Sep 29, 2025, at 12:00 Indian Standard Time.Buy Or Sell Opportunity • Aug 23Now 20% overvaluedOver the last 90 days, the stock has fallen 3.8% to ₹2.05. The fair value is estimated to be ₹1.70, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Meanwhile, the company became loss making.お知らせ • Aug 13Sundaram Multi Pap Limited, Annual General Meeting, Aug 20, 2025Sundaram Multi Pap Limited, Annual General Meeting, Aug 20, 2025.Reported Earnings • Aug 13First quarter 2026 earnings released: ₹0.01 loss per share (vs ₹0.01 profit in 1Q 2025)First quarter 2026 results: ₹0.01 loss per share (down from ₹0.01 profit in 1Q 2025). Revenue: ₹407.2m (down 4.0% from 1Q 2025). Net loss: ₹4.44m (down 276% from profit in 1Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 79 percentage points per year, which is a significant difference in performance.Board Change • Jul 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Women Independent Director Jyoti Gala was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • May 23Full year 2025 earnings released: ₹0.11 loss per share (vs ₹0.11 loss in FY 2024)Full year 2025 results: ₹0.11 loss per share (further deteriorated from ₹0.11 loss in FY 2024). Revenue: ₹1.29b (up 1.9% from FY 2024). Net loss: ₹51.2m (flat on FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance.お知らせ • May 13Sundaram Multi Pap Limited to Report Q4, 2025 Results on May 22, 2025Sundaram Multi Pap Limited announced that they will report Q4, 2025 results on May 22, 2025Buy Or Sell Opportunity • Mar 06Now 20% overvaluedOver the last 90 days, the stock has fallen 19% to ₹2.23. The fair value is estimated to be ₹1.85, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 20% over the last 3 years. Meanwhile, the company became loss making.Reported Earnings • Feb 16Third quarter 2025 earnings released: ₹0.057 loss per share (vs ₹0.05 loss in 3Q 2024)Third quarter 2025 results: ₹0.057 loss per share (further deteriorated from ₹0.05 loss in 3Q 2024). Revenue: ₹213.6m (down 2.7% from 3Q 2024). Net loss: ₹26.9m (loss widened 25% from 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.お知らせ • Feb 09Sundaram Multi Pap Limited to Report Q3, 2025 Results on Feb 14, 2025Sundaram Multi Pap Limited announced that they will report Q3, 2025 results on Feb 14, 2025Reported Earnings • Nov 16Second quarter 2025 earnings released: ₹0.039 loss per share (vs ₹0.05 loss in 2Q 2024)Second quarter 2025 results: ₹0.039 loss per share (improved from ₹0.05 loss in 2Q 2024). Revenue: ₹240.1m (up 7.6% from 2Q 2024). Net loss: ₹18.3m (loss narrowed 22% from 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.お知らせ • Nov 06Sundaram Multi Pap Limited to Report Q2, 2025 Results on Nov 14, 2024Sundaram Multi Pap Limited announced that they will report Q2, 2025 results on Nov 14, 2024お知らせ • Aug 13Sundaram Multi Pap Limited, Annual General Meeting, Sep 27, 2024Sundaram Multi Pap Limited, Annual General Meeting, Sep 27, 2024, at 14:30 Indian Standard Time.Reported Earnings • Aug 13First quarter 2025 earnings released: EPS: ₹0.01 (vs ₹0.02 loss in 1Q 2024)First quarter 2025 results: EPS: ₹0.01 (up from ₹0.02 loss in 1Q 2024). Revenue: ₹424.3m (flat on 1Q 2024). Net income: ₹2.52m (up ₹10.8m from 1Q 2024). Profit margin: 0.6% (up from net loss in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings.お知らせ • Aug 05Sundaram Multi Pap Limited to Report Q1, 2025 Results on Aug 12, 2024Sundaram Multi Pap Limited announced that they will report Q1, 2025 results on Aug 12, 2024Reported Earnings • May 30Full year 2024 earnings released: ₹0.11 loss per share (vs ₹0.055 profit in FY 2023)Full year 2024 results: ₹0.11 loss per share (down from ₹0.055 profit in FY 2023). Revenue: ₹1.27b (up 11% from FY 2023). Net loss: ₹50.8m (down 296% from profit in FY 2023). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 20% per year, which means it is tracking significantly ahead of earnings growth.New Risk • Mar 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.7% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.1% average weekly change). Market cap is less than US$100m (₹1.44b market cap, or US$17.4m).New Risk • Feb 14New major risk - Revenue and earnings growthEarnings have declined by 1.7% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.7% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₹1.54b market cap, or US$18.5m).Reported Earnings • Nov 07Second quarter 2024 earnings released: ₹0.05 loss per share (vs ₹0.04 profit in 2Q 2023)Second quarter 2024 results: ₹0.05 loss per share (down from ₹0.04 profit in 2Q 2023). Revenue: ₹224.8m (down 11% from 2Q 2023). Net loss: ₹23.5m (down 218% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth.New Risk • Oct 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Market cap is less than US$100m (₹1.58b market cap, or US$19.0m).お知らせ • Sep 01+ 2 more updatesSundaram Multi Pap Limited to Report Q4, 2024 Results on May 30, 2024Sundaram Multi Pap Limited announced that they will report Q4, 2024 results on May 30, 2024Reported Earnings • Aug 13First quarter 2024 earnings released: ₹0.02 loss per share (vs ₹0.07 profit in 1Q 2023)First quarter 2024 results: ₹0.02 loss per share (down from ₹0.07 profit in 1Q 2023). Revenue: ₹422.9m (up 63% from 1Q 2023). Net loss: ₹8.27m (down 126% from profit in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 89% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 12Sundaram Multi Pap Limited, Annual General Meeting, Sep 29, 2023Sundaram Multi Pap Limited, Annual General Meeting, Sep 29, 2023, at 11:30 Indian Standard Time.お知らせ • Aug 03Sundaram Multi Pap Limited to Report Q1, 2024 Results on Aug 11, 2023Sundaram Multi Pap Limited announced that they will report Q1, 2024 results on Aug 11, 2023Reported Earnings • May 31Full year 2023 earnings released: EPS: ₹0.05 (vs ₹0.083 in FY 2022)Full year 2023 results: EPS: ₹0.05 (down from ₹0.083 in FY 2022). Revenue: ₹1.19b (up 69% from FY 2022). Net income: ₹25.9m (down 34% from FY 2022). Profit margin: 2.2% (down from 5.6% in FY 2022). Over the last 3 years on average, earnings per share has increased by 91% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth.お知らせ • May 20Sundaram Multi Pap Limited to Report Q4, 2023 Results on May 29, 2023Sundaram Multi Pap Limited announced that they will report Q4, 2023 results on May 29, 2023Valuation Update With 7 Day Price Move • Mar 29Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹2.01, the stock trades at a trailing P/E ratio of 17.1x. Average trailing P/E is 7x in the Forestry industry in India. Total returns to shareholders of 78% over the past three years.Reported Earnings • Feb 14Third quarter 2023 earnings released: ₹0.03 loss per share (vs ₹0.03 profit in 3Q 2022)Third quarter 2023 results: ₹0.03 loss per share (down from ₹0.03 profit in 3Q 2022). Revenue: ₹227.4m (up 27% from 3Q 2022). Net loss: ₹15.6m (down 196% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 100% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.お知らせ • Feb 14Sundaram Multi Pap Limited Appoints DK Mishra as Company SecretarySundaram Multi Pap Limited announced the appointment of DK Mishra as Company Secretary of the company with effect from February 13, 2023. He is associate member of The Institute of Company Secretaries of India and Law Graduate. He is Associate Member of The Institute of Company Secretaries of India and Law Graduate and having work experience of around 6 years.お知らせ • Jan 14Sundaram Multi Pap Limited Appoints DK Mishra as Compliance OfficerSundaram Multi Pap Limited announced that the Board of Directors at their meeting held on January 13, 2023 have appointed Mr. DK Mishra as Compliance Officer of the company with effect from January 13, 2023. He is associate member of The Institute of Company Secretaries of India and Law Graduate and having work experience of around 6 years.お知らせ • Dec 01Sundaram Multi Pap Limited Announces Resignation of Khushboo Doshi as Company SecretarySundaram Multi Pap Limited announced that Ms. Khushboo Doshi has tendered her resignation from the Post of Company Secretary & Compliance Officer of the Company w.e.f. November 30, 2022.Reported Earnings • Nov 20Second quarter 2023 earnings released: EPS: ₹0.04 (vs ₹0.03 in 2Q 2022)Second quarter 2023 results: EPS: ₹0.04 (up from ₹0.03 in 2Q 2022). Revenue: ₹258.4m (up 66% from 2Q 2022). Net income: ₹20.0m (up 45% from 2Q 2022). Profit margin: 7.7% (down from 8.9% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth.お知らせ • Sep 21Sundaram Multi Pap Limited Announced Directorate AppointmentsSundaram Multi Pap Limited at its 28th Annual General Meeting regularized the appointment of Mrs. Jyoti Chandrakant Gala and Mr. Mahesh Devji Bhanushali as an Non-executive Director not liable to retire by rotation, to hold office for a term of five consecutive years. Date of Appointment: w.e.f Board Meeting held on June 27, 2022. Mrs. Jyoti Gala is Non-Executive Independent Women Director of the Company. She is qualified B.HSC degree holder. She has done her specialization in textile designing. She has great skills in product designing. A very enthusiastic and conversant person having keen interest in the current social media and new marketing trends. Mr. Mahesh Devji Bhanushali is Non- Executive Independent Director of the Company. He has done his MBA from Welingkar Institute of Management. He is skilled in Business Development, Strategic planning and Staff Management. A self-motivated professional successful in seizing viable opportunities for expansion and innovation in business. He has his background in increasing profits, reducing costs, and transforming customer service standards. Experienced in leading and supervising operational and sales teams.お知らせ • Aug 26+ 2 more updatesSundaram Multi Pap Limited to Report Q3, 2023 Results on Feb 14, 2023Sundaram Multi Pap Limited announced that they will report Q3, 2023 results on Feb 14, 2023Reported Earnings • Aug 13First quarter 2023 earnings released: EPS: ₹0.07 (vs ₹0.02 loss in 1Q 2022)First quarter 2023 results: EPS: ₹0.07 (up from ₹0.02 loss in 1Q 2022). Revenue: ₹259.6m (up 120% from 1Q 2022). Net income: ₹32.3m (up ₹42.2m from 1Q 2022). Profit margin: 12% (up from net loss in 1Q 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Aug 05Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹3.33, the stock trades at a trailing P/E ratio of 40.4x. Average trailing P/E is 15x in the Forestry industry in India. Total returns to shareholders of 136% over the past three years.お知らせ • Aug 03Sundaram Multi Pap Limited to Report Q1, 2023 Results on Aug 10, 2022Sundaram Multi Pap Limited announced that they will report Q1, 2023 results at 3:30 PM, Indian Standard Time on Aug 10, 2022Valuation Update With 7 Day Price Move • Jun 29Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹3.01, the stock trades at a trailing P/E ratio of 36.5x. Average trailing P/E is 12x in the Forestry industry in India. Total returns to shareholders of 75% over the past three years.Reported Earnings • Jun 03Full year 2022 earnings released: EPS: ₹0.09 (vs ₹0.19 loss in FY 2021)Full year 2022 results: EPS: ₹0.09 (up from ₹0.19 loss in FY 2021). Revenue: ₹730.6m (up 44% from FY 2021). Net income: ₹39.1m (up ₹127.5m from FY 2021). Profit margin: 5.4% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.お知らせ • May 31Sundaram Multi Pap Limited Announces Resignation of Paresh Jain as Independent DirectorSundaram Multi Pap Limited announced that at its board meeting held on May 30, 2022, has inter-alia transacted resignation of Mr. Paresh Jain (Independent Director) vide his letter dated May 26, 2022, effective May 30, 2022.お知らせ • May 20Sundaram Multi Pap Limited to Report Q4, 2022 Results on May 30, 2022Sundaram Multi Pap Limited announced that they will report Q4, 2022 results on May 30, 2022Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Paresh Kumar Jain was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Apr 06Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Paresh Kumar Jain was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Mar 31Sundaram Multi Pap Limited Announces Resignation of Minjal Kadakia as Independent DirectorSundaram Multi Pap Limited informed that Ms. Minjal Kadakia, Independent Director of the Company has vide her resignation letter dated March 29, 2022, resigned from the Board of the Company with immediate effect, on account of personal commitments and other pre-occupations.Reported Earnings • Jan 26Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹0.03 (up from ₹0.05 loss in 3Q 2021). Revenue: ₹185.3m (up 106% from 3Q 2021). Net income: ₹16.2m (up ₹37.8m from 3Q 2021). Profit margin: 8.8% (up from net loss in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 106 percentage points per year, which is a significant difference in performance.Reported Earnings • Nov 04Second quarter 2022 earnings released: EPS ₹0.03 (vs ₹0.06 loss in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹162.6m (up 94% from 2Q 2021). Net income: ₹13.8m (up ₹44.3m from 2Q 2021). Profit margin: 8.5% (up from net loss in 2Q 2021).Reported Earnings • Jun 26Full year 2021 earnings released: ₹0.19 loss per share (vs ₹0.057 loss in FY 2020)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: ₹530.4m (down 45% from FY 2020). Net loss: ₹88.4m (loss widened 227% from FY 2020). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.Is New 90 Day High Low • Mar 05New 90-day low: ₹1.30The company is down 22% from its price of ₹1.67 on 04 December 2020. The Indian market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 39% over the same period.Reported Earnings • Feb 15Third quarter 2021 earnings released: ₹0.05 loss per shareThe company reported a poor third quarter result with increased losses, weaker revenues and weaker control over costs. Third quarter 2021 results: Revenue: ₹97.5m (down 33% from 3Q 2020). Net loss: ₹21.5m (loss widened ₹21.4m from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.お知らせ • Feb 13Sundaram Multi Pap Limited Approves Appointment of Bhavika Dalal as the Company Secretary & Compliance Officer and Key Managerial PersonnelSundaram Multi Pap Limited Approved the appointment of Ms. Bhavika Dalal as the Company Secretary & Compliance Officer and Key Managerial Personnel of the Company with effect from February 12, 2021.お知らせ • Feb 03Sundaram Multi Pap Limited to Report Q3, 2021 Results on Feb 12, 2021Sundaram Multi Pap Limited announced that they will report Q3, 2021 results on Feb 12, 2021お知らせ • Jan 16Sundaram Multi Pap Limited Announces the Resignation of Bhavesh Chheda from the Post of Company Secretary & Key Managerial Personnel of the CompanySundaram Multi Pap Limited announced that Mr. Bhavesh Chheda has tendered his resignation from the post of Company Secretary & Key Managerial Personnel of the Company with effect from closure of business hours of January 15, 2021. The Board of Directors have accepted the said resignation and relieved him from his responsibilities from the post of Company Secretary & Key Managerial Personnel of the Company with effect from closure of business hours of January 15, 2021. However, Mr. Bhavesh Chheda shall continue to be the Compliance Officer of the Company up to the date of upcoming Board Meeting of the Company.Is New 90 Day High Low • Jan 05New 90-day high: ₹1.68The company is up 51% from its price of ₹1.11 on 07 October 2020. The Indian market is up 20% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Forestry industry, which is up 29% over the same period.Is New 90 Day High Low • Dec 01New 90-day high: ₹1.36The company is up 5.0% from its price of ₹1.29 on 02 September 2020. The Indian market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 7.0% over the same period.Is New 90 Day High Low • Oct 14New 90-day low: ₹1.10The company is down 21% from its price of ₹1.39 on 16 July 2020. The Indian market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 4.0% over the same period.Is New 90 Day High Low • Sep 28New 90-day low: ₹1.11The company is down 39% from its price of ₹1.82 on 30 June 2020. The Indian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 3.0% over the same period.決済の安定と成長配当データの取得安定した配当: 533166の 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: 533166の配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Sundaram Multi Pap 配当利回り対市場533166 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (533166)0%市場下位25% (IN)0.3%市場トップ25% (IN)1.4%業界平均 (Forestry)0.6%アナリスト予想 (533166) (最長3年)n/a注目すべき配当: 533166は最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: 533166は最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: 533166 Indian市場において目立った配当金を支払っていません。株主配当金キャッシュフローカバレッジ: 533166が配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YIN 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/05 23:41終値2026/08/05 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Sundaram Multi Pap Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Aug 01Sundaram Multi Pap Limited to Report Q1, 2027 Results on Aug 13, 2026Sundaram Multi Pap Limited announced that they will report Q1, 2027 results on Aug 13, 2026
Reported Earnings • May 26Full year 2026 earnings released: EPS: ₹0.07 (vs ₹0.11 loss in FY 2025)Full year 2026 results: EPS: ₹0.07 (up from ₹0.11 loss in FY 2025). Revenue: ₹1.39b (up 9.2% from FY 2025). Net income: ₹31.8m (up ₹83.0m from FY 2025). Profit margin: 2.3% (up from net loss in FY 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings.
お知らせ • May 15Sundaram Multi Pap Limited to Report Q4, 2026 Results on May 25, 2026Sundaram Multi Pap Limited announced that they will report Q4, 2026 results on May 25, 2026
Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1.29, the stock trades at a trailing P/E ratio of 53x. Average trailing P/E is 26x in the Forestry industry in India. Total loss to shareholders of 48% over the past three years.
Reported Earnings • Feb 16Third quarter 2026 earnings released: EPS: ₹0.03 (vs ₹0.057 loss in 3Q 2025)Third quarter 2026 results: EPS: ₹0.03 (up from ₹0.057 loss in 3Q 2025). Revenue: ₹269.3m (up 26% from 3Q 2025). Net income: ₹16.2m (up ₹43.1m from 3Q 2025). Profit margin: 6.0% (up from net loss in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.
お知らせ • Feb 06Sundaram Multi Pap Limited to Report Q3, 2026 Results on Feb 14, 2026Sundaram Multi Pap Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 14, 2026
New Risk • Dec 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 0.2% per year over the past 5 years. Market cap is less than US$10m (₹824.5m market cap, or US$9.18m). Minor Risk Share price has been volatile over the past 3 months (6.8% average weekly change).
Reported Earnings • Nov 15Second quarter 2026 earnings released: EPS: ₹0.02 (vs ₹0.039 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹0.02 (up from ₹0.039 loss in 2Q 2025). Revenue: ₹260.4m (up 8.5% from 2Q 2025). Net income: ₹8.30m (up ₹26.6m from 2Q 2025). Profit margin: 3.2% (up from net loss in 2Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.
お知らせ • Nov 04Sundaram Multi Pap Limited to Report Q2, 2026 Results on Nov 13, 2025Sundaram Multi Pap Limited announced that they will report Q2, 2026 results on Nov 13, 2025
お知らせ • Oct 17Sundaram Multi Pap Limited announced that it expects to receive INR 235.84 million in fundingSundaram Multi Pap Ltd. (BSE:533166) announced a private placement transaction on October 16, 2025. The company will issue 7,04,00,000 fully Paid-up Equity Shares of the Company having a Face Value of INR 1 each at an issue price of NR 3.35 for gross proceeds of INR 235,840,000 on a preferential basis. The company announced that transaction is subject to approval of shareholders at Extra ordinary general meeting to be held on November 12, 2025.
New Risk • Oct 07New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹881.4m (US$9.93m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company.
お知らせ • Aug 25Sundaram Multi Pap Limited, Annual General Meeting, Sep 29, 2025Sundaram Multi Pap Limited, Annual General Meeting, Sep 29, 2025, at 12:00 Indian Standard Time.
Buy Or Sell Opportunity • Aug 23Now 20% overvaluedOver the last 90 days, the stock has fallen 3.8% to ₹2.05. The fair value is estimated to be ₹1.70, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Meanwhile, the company became loss making.
お知らせ • Aug 13Sundaram Multi Pap Limited, Annual General Meeting, Aug 20, 2025Sundaram Multi Pap Limited, Annual General Meeting, Aug 20, 2025.
Reported Earnings • Aug 13First quarter 2026 earnings released: ₹0.01 loss per share (vs ₹0.01 profit in 1Q 2025)First quarter 2026 results: ₹0.01 loss per share (down from ₹0.01 profit in 1Q 2025). Revenue: ₹407.2m (down 4.0% from 1Q 2025). Net loss: ₹4.44m (down 276% from profit in 1Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 79 percentage points per year, which is a significant difference in performance.
Board Change • Jul 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Women Independent Director Jyoti Gala was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • May 23Full year 2025 earnings released: ₹0.11 loss per share (vs ₹0.11 loss in FY 2024)Full year 2025 results: ₹0.11 loss per share (further deteriorated from ₹0.11 loss in FY 2024). Revenue: ₹1.29b (up 1.9% from FY 2024). Net loss: ₹51.2m (flat on FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance.
お知らせ • May 13Sundaram Multi Pap Limited to Report Q4, 2025 Results on May 22, 2025Sundaram Multi Pap Limited announced that they will report Q4, 2025 results on May 22, 2025
Buy Or Sell Opportunity • Mar 06Now 20% overvaluedOver the last 90 days, the stock has fallen 19% to ₹2.23. The fair value is estimated to be ₹1.85, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 20% over the last 3 years. Meanwhile, the company became loss making.
Reported Earnings • Feb 16Third quarter 2025 earnings released: ₹0.057 loss per share (vs ₹0.05 loss in 3Q 2024)Third quarter 2025 results: ₹0.057 loss per share (further deteriorated from ₹0.05 loss in 3Q 2024). Revenue: ₹213.6m (down 2.7% from 3Q 2024). Net loss: ₹26.9m (loss widened 25% from 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 09Sundaram Multi Pap Limited to Report Q3, 2025 Results on Feb 14, 2025Sundaram Multi Pap Limited announced that they will report Q3, 2025 results on Feb 14, 2025
Reported Earnings • Nov 16Second quarter 2025 earnings released: ₹0.039 loss per share (vs ₹0.05 loss in 2Q 2024)Second quarter 2025 results: ₹0.039 loss per share (improved from ₹0.05 loss in 2Q 2024). Revenue: ₹240.1m (up 7.6% from 2Q 2024). Net loss: ₹18.3m (loss narrowed 22% from 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.
お知らせ • Nov 06Sundaram Multi Pap Limited to Report Q2, 2025 Results on Nov 14, 2024Sundaram Multi Pap Limited announced that they will report Q2, 2025 results on Nov 14, 2024
お知らせ • Aug 13Sundaram Multi Pap Limited, Annual General Meeting, Sep 27, 2024Sundaram Multi Pap Limited, Annual General Meeting, Sep 27, 2024, at 14:30 Indian Standard Time.
Reported Earnings • Aug 13First quarter 2025 earnings released: EPS: ₹0.01 (vs ₹0.02 loss in 1Q 2024)First quarter 2025 results: EPS: ₹0.01 (up from ₹0.02 loss in 1Q 2024). Revenue: ₹424.3m (flat on 1Q 2024). Net income: ₹2.52m (up ₹10.8m from 1Q 2024). Profit margin: 0.6% (up from net loss in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings.
お知らせ • Aug 05Sundaram Multi Pap Limited to Report Q1, 2025 Results on Aug 12, 2024Sundaram Multi Pap Limited announced that they will report Q1, 2025 results on Aug 12, 2024
Reported Earnings • May 30Full year 2024 earnings released: ₹0.11 loss per share (vs ₹0.055 profit in FY 2023)Full year 2024 results: ₹0.11 loss per share (down from ₹0.055 profit in FY 2023). Revenue: ₹1.27b (up 11% from FY 2023). Net loss: ₹50.8m (down 296% from profit in FY 2023). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 20% per year, which means it is tracking significantly ahead of earnings growth.
New Risk • Mar 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.7% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.1% average weekly change). Market cap is less than US$100m (₹1.44b market cap, or US$17.4m).
New Risk • Feb 14New major risk - Revenue and earnings growthEarnings have declined by 1.7% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.7% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₹1.54b market cap, or US$18.5m).
Reported Earnings • Nov 07Second quarter 2024 earnings released: ₹0.05 loss per share (vs ₹0.04 profit in 2Q 2023)Second quarter 2024 results: ₹0.05 loss per share (down from ₹0.04 profit in 2Q 2023). Revenue: ₹224.8m (down 11% from 2Q 2023). Net loss: ₹23.5m (down 218% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth.
New Risk • Oct 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Market cap is less than US$100m (₹1.58b market cap, or US$19.0m).
お知らせ • Sep 01+ 2 more updatesSundaram Multi Pap Limited to Report Q4, 2024 Results on May 30, 2024Sundaram Multi Pap Limited announced that they will report Q4, 2024 results on May 30, 2024
Reported Earnings • Aug 13First quarter 2024 earnings released: ₹0.02 loss per share (vs ₹0.07 profit in 1Q 2023)First quarter 2024 results: ₹0.02 loss per share (down from ₹0.07 profit in 1Q 2023). Revenue: ₹422.9m (up 63% from 1Q 2023). Net loss: ₹8.27m (down 126% from profit in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 89% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 12Sundaram Multi Pap Limited, Annual General Meeting, Sep 29, 2023Sundaram Multi Pap Limited, Annual General Meeting, Sep 29, 2023, at 11:30 Indian Standard Time.
お知らせ • Aug 03Sundaram Multi Pap Limited to Report Q1, 2024 Results on Aug 11, 2023Sundaram Multi Pap Limited announced that they will report Q1, 2024 results on Aug 11, 2023
Reported Earnings • May 31Full year 2023 earnings released: EPS: ₹0.05 (vs ₹0.083 in FY 2022)Full year 2023 results: EPS: ₹0.05 (down from ₹0.083 in FY 2022). Revenue: ₹1.19b (up 69% from FY 2022). Net income: ₹25.9m (down 34% from FY 2022). Profit margin: 2.2% (down from 5.6% in FY 2022). Over the last 3 years on average, earnings per share has increased by 91% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth.
お知らせ • May 20Sundaram Multi Pap Limited to Report Q4, 2023 Results on May 29, 2023Sundaram Multi Pap Limited announced that they will report Q4, 2023 results on May 29, 2023
Valuation Update With 7 Day Price Move • Mar 29Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹2.01, the stock trades at a trailing P/E ratio of 17.1x. Average trailing P/E is 7x in the Forestry industry in India. Total returns to shareholders of 78% over the past three years.
Reported Earnings • Feb 14Third quarter 2023 earnings released: ₹0.03 loss per share (vs ₹0.03 profit in 3Q 2022)Third quarter 2023 results: ₹0.03 loss per share (down from ₹0.03 profit in 3Q 2022). Revenue: ₹227.4m (up 27% from 3Q 2022). Net loss: ₹15.6m (down 196% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 100% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
お知らせ • Feb 14Sundaram Multi Pap Limited Appoints DK Mishra as Company SecretarySundaram Multi Pap Limited announced the appointment of DK Mishra as Company Secretary of the company with effect from February 13, 2023. He is associate member of The Institute of Company Secretaries of India and Law Graduate. He is Associate Member of The Institute of Company Secretaries of India and Law Graduate and having work experience of around 6 years.
お知らせ • Jan 14Sundaram Multi Pap Limited Appoints DK Mishra as Compliance OfficerSundaram Multi Pap Limited announced that the Board of Directors at their meeting held on January 13, 2023 have appointed Mr. DK Mishra as Compliance Officer of the company with effect from January 13, 2023. He is associate member of The Institute of Company Secretaries of India and Law Graduate and having work experience of around 6 years.
お知らせ • Dec 01Sundaram Multi Pap Limited Announces Resignation of Khushboo Doshi as Company SecretarySundaram Multi Pap Limited announced that Ms. Khushboo Doshi has tendered her resignation from the Post of Company Secretary & Compliance Officer of the Company w.e.f. November 30, 2022.
Reported Earnings • Nov 20Second quarter 2023 earnings released: EPS: ₹0.04 (vs ₹0.03 in 2Q 2022)Second quarter 2023 results: EPS: ₹0.04 (up from ₹0.03 in 2Q 2022). Revenue: ₹258.4m (up 66% from 2Q 2022). Net income: ₹20.0m (up 45% from 2Q 2022). Profit margin: 7.7% (down from 8.9% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth.
お知らせ • Sep 21Sundaram Multi Pap Limited Announced Directorate AppointmentsSundaram Multi Pap Limited at its 28th Annual General Meeting regularized the appointment of Mrs. Jyoti Chandrakant Gala and Mr. Mahesh Devji Bhanushali as an Non-executive Director not liable to retire by rotation, to hold office for a term of five consecutive years. Date of Appointment: w.e.f Board Meeting held on June 27, 2022. Mrs. Jyoti Gala is Non-Executive Independent Women Director of the Company. She is qualified B.HSC degree holder. She has done her specialization in textile designing. She has great skills in product designing. A very enthusiastic and conversant person having keen interest in the current social media and new marketing trends. Mr. Mahesh Devji Bhanushali is Non- Executive Independent Director of the Company. He has done his MBA from Welingkar Institute of Management. He is skilled in Business Development, Strategic planning and Staff Management. A self-motivated professional successful in seizing viable opportunities for expansion and innovation in business. He has his background in increasing profits, reducing costs, and transforming customer service standards. Experienced in leading and supervising operational and sales teams.
お知らせ • Aug 26+ 2 more updatesSundaram Multi Pap Limited to Report Q3, 2023 Results on Feb 14, 2023Sundaram Multi Pap Limited announced that they will report Q3, 2023 results on Feb 14, 2023
Reported Earnings • Aug 13First quarter 2023 earnings released: EPS: ₹0.07 (vs ₹0.02 loss in 1Q 2022)First quarter 2023 results: EPS: ₹0.07 (up from ₹0.02 loss in 1Q 2022). Revenue: ₹259.6m (up 120% from 1Q 2022). Net income: ₹32.3m (up ₹42.2m from 1Q 2022). Profit margin: 12% (up from net loss in 1Q 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹3.33, the stock trades at a trailing P/E ratio of 40.4x. Average trailing P/E is 15x in the Forestry industry in India. Total returns to shareholders of 136% over the past three years.
お知らせ • Aug 03Sundaram Multi Pap Limited to Report Q1, 2023 Results on Aug 10, 2022Sundaram Multi Pap Limited announced that they will report Q1, 2023 results at 3:30 PM, Indian Standard Time on Aug 10, 2022
Valuation Update With 7 Day Price Move • Jun 29Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹3.01, the stock trades at a trailing P/E ratio of 36.5x. Average trailing P/E is 12x in the Forestry industry in India. Total returns to shareholders of 75% over the past three years.
Reported Earnings • Jun 03Full year 2022 earnings released: EPS: ₹0.09 (vs ₹0.19 loss in FY 2021)Full year 2022 results: EPS: ₹0.09 (up from ₹0.19 loss in FY 2021). Revenue: ₹730.6m (up 44% from FY 2021). Net income: ₹39.1m (up ₹127.5m from FY 2021). Profit margin: 5.4% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.
お知らせ • May 31Sundaram Multi Pap Limited Announces Resignation of Paresh Jain as Independent DirectorSundaram Multi Pap Limited announced that at its board meeting held on May 30, 2022, has inter-alia transacted resignation of Mr. Paresh Jain (Independent Director) vide his letter dated May 26, 2022, effective May 30, 2022.
お知らせ • May 20Sundaram Multi Pap Limited to Report Q4, 2022 Results on May 30, 2022Sundaram Multi Pap Limited announced that they will report Q4, 2022 results on May 30, 2022
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Paresh Kumar Jain was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Apr 06Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Paresh Kumar Jain was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Mar 31Sundaram Multi Pap Limited Announces Resignation of Minjal Kadakia as Independent DirectorSundaram Multi Pap Limited informed that Ms. Minjal Kadakia, Independent Director of the Company has vide her resignation letter dated March 29, 2022, resigned from the Board of the Company with immediate effect, on account of personal commitments and other pre-occupations.
Reported Earnings • Jan 26Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹0.03 (up from ₹0.05 loss in 3Q 2021). Revenue: ₹185.3m (up 106% from 3Q 2021). Net income: ₹16.2m (up ₹37.8m from 3Q 2021). Profit margin: 8.8% (up from net loss in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 106 percentage points per year, which is a significant difference in performance.
Reported Earnings • Nov 04Second quarter 2022 earnings released: EPS ₹0.03 (vs ₹0.06 loss in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹162.6m (up 94% from 2Q 2021). Net income: ₹13.8m (up ₹44.3m from 2Q 2021). Profit margin: 8.5% (up from net loss in 2Q 2021).
Reported Earnings • Jun 26Full year 2021 earnings released: ₹0.19 loss per share (vs ₹0.057 loss in FY 2020)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: ₹530.4m (down 45% from FY 2020). Net loss: ₹88.4m (loss widened 227% from FY 2020). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
Is New 90 Day High Low • Mar 05New 90-day low: ₹1.30The company is down 22% from its price of ₹1.67 on 04 December 2020. The Indian market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 39% over the same period.
Reported Earnings • Feb 15Third quarter 2021 earnings released: ₹0.05 loss per shareThe company reported a poor third quarter result with increased losses, weaker revenues and weaker control over costs. Third quarter 2021 results: Revenue: ₹97.5m (down 33% from 3Q 2020). Net loss: ₹21.5m (loss widened ₹21.4m from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.
お知らせ • Feb 13Sundaram Multi Pap Limited Approves Appointment of Bhavika Dalal as the Company Secretary & Compliance Officer and Key Managerial PersonnelSundaram Multi Pap Limited Approved the appointment of Ms. Bhavika Dalal as the Company Secretary & Compliance Officer and Key Managerial Personnel of the Company with effect from February 12, 2021.
お知らせ • Feb 03Sundaram Multi Pap Limited to Report Q3, 2021 Results on Feb 12, 2021Sundaram Multi Pap Limited announced that they will report Q3, 2021 results on Feb 12, 2021
お知らせ • Jan 16Sundaram Multi Pap Limited Announces the Resignation of Bhavesh Chheda from the Post of Company Secretary & Key Managerial Personnel of the CompanySundaram Multi Pap Limited announced that Mr. Bhavesh Chheda has tendered his resignation from the post of Company Secretary & Key Managerial Personnel of the Company with effect from closure of business hours of January 15, 2021. The Board of Directors have accepted the said resignation and relieved him from his responsibilities from the post of Company Secretary & Key Managerial Personnel of the Company with effect from closure of business hours of January 15, 2021. However, Mr. Bhavesh Chheda shall continue to be the Compliance Officer of the Company up to the date of upcoming Board Meeting of the Company.
Is New 90 Day High Low • Jan 05New 90-day high: ₹1.68The company is up 51% from its price of ₹1.11 on 07 October 2020. The Indian market is up 20% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Forestry industry, which is up 29% over the same period.
Is New 90 Day High Low • Dec 01New 90-day high: ₹1.36The company is up 5.0% from its price of ₹1.29 on 02 September 2020. The Indian market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 7.0% over the same period.
Is New 90 Day High Low • Oct 14New 90-day low: ₹1.10The company is down 21% from its price of ₹1.39 on 16 July 2020. The Indian market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 4.0% over the same period.
Is New 90 Day High Low • Sep 28New 90-day low: ₹1.11The company is down 39% from its price of ₹1.82 on 30 June 2020. The Indian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 3.0% over the same period.